M&A Deal Summary

DexCom Acquires TypeZero Technologies

On August 22, 2018, DexCom acquired information technology company TypeZero Technologies

Acquisition Highlights
  • This is DexCom’s 1st transaction in the Information Technology sector.
  • This is DexCom’s 2nd transaction in the United States.
  • This is DexCom’s 1st transaction in Virginia.

M&A Deal Summary

Date 2018-08-22
Target TypeZero Technologies
Sector Information Technology
Buyer(s) DexCom
Deal Type Add-on Acquisition

Target

TypeZero Technologies

Charlottesville, Virginia, United States
TypeZero Technologies, Inc. is a provider of an inControl diabetes management system, designed to provide personalized diabetes management solutions including technology to automatically adjust and regulate insulin delivery. TypeZero Technologies was founded in 2013 and is based in Charlottesville, Virginia.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DexCom

San Diego, California, United States

Category Company
Founded 1999
Sector Medical Products
Employees838
DESCRIPTION

DexCom, Inc. is a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems.


DEAL STATS #
Overall 3 of 3
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 3 of 3
State: Virginia M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-02 Nintamed

Edinburg, United Kingdom

Nintamed is a distributor of glucose monitoring systems.

Buy -